SCHEMBL1718185

SCHEMBL1718185

O=C(c1nn2c(C(F)(F)F)cc(-c3cc(Br)cs3)nc2c1Br)N1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.60
USP2 O75604 1/20 0.55
ALDH1A1 P00352 10/20 0.51
KDM4E B2RXH2 5/20 0.51
GAA P10253 3/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
HPGD P15428 7/20 0.51
HTT P42858 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 3/20 0.47
MEN1 O00255 3/20 0.46
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
ALOX12 P18054 1/20 0.45
ESR1 P03372 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719497 0.90 KMT2A (0.59) KMT2AUSP2ALDH1A1KDM4EGAA
SCHEMBL1717661 0.87 ALDH1A1 (0.69) KMT2AUSP2ALDH1A1KDM4EGAA
SCHEMBL4210838 0.85 HPGD (0.70) USP2ALDH1A1KDM4EGAACASP1
SCHEMBL1718598 0.83 USP2 (0.79) USP2ALDH1A1KDM4EGAACASP1
SCHEMBL1718497 0.80 ALDH1A1 (0.68) KMT2AUSP2ALDH1A1KDM4EGAA
SCHEMBL4206778 0.79 ALDH1A1 (0.81) KMT2AUSP2ALDH1A1KDM4EGAA
SCHEMBL1718156 0.77 HTT (0.71) KMT2AALDH1A1KDM4EGAACASP1
SCHEMBL1718611 0.77 KDM4E (0.70) KMT2AALDH1A1KDM4EGAACASP1
SCHEMBL1718397 0.76 USP2 (0.74) KMT2AUSP2ALDH1A1KDM4EGAA
SCHEMBL1718386 0.76 KMT2A (0.67) KMT2AUSP2ALDH1A1KDM4ECASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed